rs200513352
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_007059.4(KPTN):āc.761T>Cā(p.Ile254Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000425 in 1,613,504 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_007059.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KPTN | NM_007059.4 | c.761T>C | p.Ile254Thr | missense_variant | 8/12 | ENST00000338134.8 | NP_008990.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KPTN | ENST00000338134.8 | c.761T>C | p.Ile254Thr | missense_variant | 8/12 | 1 | NM_007059.4 | ENSP00000337850.2 |
Frequencies
GnomAD3 genomes AF: 0.000902 AC: 137AN: 151946Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.000599 AC: 149AN: 248580Hom.: 1 AF XY: 0.000600 AC XY: 81AN XY: 135046
GnomAD4 exome AF: 0.000375 AC: 548AN: 1461440Hom.: 1 Cov.: 32 AF XY: 0.000370 AC XY: 269AN XY: 727070
GnomAD4 genome AF: 0.000901 AC: 137AN: 152064Hom.: 1 Cov.: 31 AF XY: 0.000955 AC XY: 71AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 22, 2016 | - - |
Macrocephaly-developmental delay syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 12, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at